1Ransom R F,Lam N G,Hallett M A,et al.Glucocorticoids protect and enhance recovery of cultured murine podocytes via actin filament stabilization[J].Kidney international,2005,68 (6):2473-2483.
2Kidney Disease:Improving Global Outcomes (KDIGO) glomerulonephritis Work Group.KDIGO Clinical Practice Guidelines for Glomerulonephritis[J].Kidney Int 2 (Suppl 2):139-274,2012.Available at:http://www.kdigo.org/clinical_practice_guidelines/pdf/KDIGO-GN-Guideline.pdf,[Data accessed:12 July 2012].
3Azib S,Macher M A,Kwon T,et al.Cyclophosphamide in steroid-dependent nephrotic syndrome[J].Pediatric Nephrology,2011,26(6):927-932.
4Durkan A,Hodson E M,Willis N S,et al.Non-corticosteroid treatment for nephrotic syndrome in children[J].the Cochrane library,2007.
5Kyrieleis H A C,Levtchenko E N,Wetzels J F M.Long-term outcome after cyclophosphamide treatment in children with steroid-dependent and frequently relapsing minimal change nephrotic syndrome[J].American Journal of Kidney Diseases,2007,49(5):592-597.
6Cammas B,Harambat J,Bertholet-Thomas A,et al.Long-term effects of cyclophosphamide therapy in steroid-dependent or frequently relapsing idiopathic nephrotic syndrome[J].Nephrology Dialysis Transplantation,2011,26(1):178-184.
7Zagury A,de Oliveira A L,de Moraes C A P,et al.Long-term follow-up after cyclophosphamide therapy in steroid-dependent nephrotic syndrome[J].Pediatric Nephrology,2011,26(6):915-920.
8Durkan A,Hodson E M,Willis N S,et al.Non-corticosteroid treatment for nephrotic syndrome in children[J].the Cochrane library,2007..
9Faul C,Donnelly M,Merscher-Gomez S,et al.The actin cytoskeleton of kidney podocytes is a direct target of the antiproteinuric effect of cyclosporine A[J].Nature medicine,2008,14 (9):931-938.
10Cattran D C,Alexopoulos E,Heering P,et al.Cyclosporin in idiopathic glomerular disease associated with the nephrotic syndrome:workshop recommendations[J].Kidney international,2007,72(12):1429-1447.
